Ruth Exner
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
-
- Bone health and osteoporosis research
Papers in
-
- Breast Cancer Treatment Studies 18
- Oncology 13
- Bone health and treatments 6
- Co-authors
- Florian Fitzal (22 shared papers)Barbara Wessner (2 shared papers)N. Manhart (2 shared papers)Erich Roth (4 shared papers)Michael Gnant (18 shared papers)Andreas Spittler (3 shared papers)Rudolf Oehler (4 shared papers)R. Jakesz (10 shared papers)
- Journals
- British Journal of Cancer (5 papers)Therapeutic Advances in Medical Oncology (3 papers)The Lancet Oncology (2 papers)Breast Cancer Research and Treatment (2 papers)Clinical Cancer Research (2 papers)
- Partner nations
- AustriaSwitzerlandLithuania
In The Last Decade
Ruth Exner
47 papers receiving 1.8k citations
Ruth Exner's Hit Papers
Peers
Comparison fields: 5 of 93
- Cancer Research 389
- Orthopedics and Sports Medicine 214
- Oncology 520
- Biochemistry 52
- Nutrition and Dietetics 102
Countries citing papers authored by Ruth Exner
This map shows the geographic impact of Ruth Exner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth Exner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth Exner more than expected).
Fields of papers citing papers by Ruth Exner
This network shows the impact of papers produced by Ruth Exner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth Exner. The network helps show where Ruth Exner may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruth Exner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial Hit paper breakdown → | 2015 | 427 |
| 2 | 2019 | 194 | |
| 3 | 2002 | 188 | |
| 4 | 2021 | 142 | |
| 5 | Therapeutic potential of glutathione. | 2000 | 90 |
| 6 | 2022 | 85 | |
| 7 | 2003 | 53 | |
| 8 | 2013 | 50 | |
| 9 | 2021 | 44 | |
| 10 | 2020 | 43 | |
| 11 | 2002 | 42 | |
| 12 | 2003 | 39 | |
| 13 | 2019 | 37 | |
| 14 | 2017 | 36 | |
| 15 | 2016 | 34 | |
| 16 | 2020 | 34 | |
| 17 | 2014 | 30 | |
| 18 | 2017 | 26 | |
| 19 | 2015 | 23 | |
| 20 | 2023 | 23 |
About Ruth Exner
Ruth Exner is a scholar working on Cancer Research, Oncology, Surgery, Hematology and Pulmonary and Respiratory Medicine, having authored 47 papers that have together received 1.8k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (18 papers), Bone health and treatments (6 papers), Breast Implant and Reconstruction (5 papers), Brain Metastases and Treatment (5 papers), Acute Myeloid Leukemia Research (3 papers), Bone health and osteoporosis research (2 papers), Sulfur Compounds in Biology (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Cancer Research (389 citations), Orthopedics and Sports Medicine (214 citations), Oncology (520 citations), Biochemistry (52 citations) and Nutrition and Dietetics (102 citations). Ruth Exner has collaborated with scholars based in Austria, Switzerland and Lithuania. Frequent co-authors include Florian Fitzal, Barbara Wessner, N. Manhart, Erich Roth, Michael Gnant, Andreas Spittler, Rudolf Oehler, R. Jakesz, Eva-Maria Strasser and Kerstin Wimmer. Their work appears in journals such as British Journal of Cancer, Therapeutic Advances in Medical Oncology, The Lancet Oncology, Breast Cancer Research and Treatment and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.